Targeting the CBM signalosome complex induces regulatory T cells to inflame the tumor microenvironment

• 收藏
• 分享

专利权人:

The General Hospital Corporation

发明人:

MEMPEL, Thorsten R.,DI PILATO, Mauro

申请号：

AU2018395291

公开号：

AU2018395291A1

申请日:

2018.12.28

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

Described herein are methods and compositions for the treatment of cancer. Aspects include administering (1) an agent that inhibits activity of a CBM signalosome complex, or (2) a cell engineered to have reduced CBM signalosome complex levels to a subject having cancer. In various embodiment, the methods further comprise administering second therapeutic, for example, a checkpoint inhibitor or anti-cancer therapy, to the subject.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/